chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Flu like symptoms; Just doesn't feel good; Woke up achy; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), MALAISE (Just doesn't feel good) and MYALGIA (Woke up achy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No Historical condition reported).   On 08-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), MALAISE (Just doesn't feel good) and MYALGIA (Woke up achy). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), MALAISE (Just doesn't feel good) and MYALGIA (Woke up achy) outcome was unknown. Not Provided          No relevant concomitant medications were reported.  No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not applicable.
devel pleurisy 24hrs p/vax;hospitalized for 7-10d rx ATB
Employee given vaccine at 1445. She stayed 10 minutes in nursesd office after vaccine with no problems. She went back to work in her department. At 1515 she began to feel light-headed, nauseated, and dry mouth. She returned to the nurses station where she was checked by the RN. Findings include employee presented with facial flushing, pale, weakness, and dry mouth. Employees airway was unobstructed and breathing was normal. B/P 138/98 HR 84 and O2 Sat 99%. Employee remained in the nurses office for 45 minutes with very little changes. She did call her PCP to report the symptoms and was told to seek ER treament if condition worsened. Employee went home and called the nurse later that evening to report she had 1 bout of emesis. The following day she reported she felt fine.
This case was reported by a pharmacy intern and described the occurrence of nausea in a 53-year-old female subject who was vaccinated with Engerix-B for prophylaxis. Concurrent vaccination included Vaqta. The subject was not on any concurrent medications and was reported to be in good health. On 14 April 2006, the subject received a 3rd dose of Engerix-B at 20 mcg in the right deltoid, Lot number AHBVB141AA. On 15 April 2006, one day after vaccination with Engerix-B and Vaqta, the subject experienced gastrointestinal complaints. abdominal pain, nausea, stomach cramping, chills, back pain, and fatigue. At the time of reporting the events were unresolved. The pharmacy intern considered the events were possibly related to vaccination with Engerix-B. On 24 April 2006, follow-up information was reported by a pharmacist. She reported that the subject "was complaining mostly about gastrointestinal complaints not joint pain".  Follow-up information received on 02 June 2006 indicated that the subject had a medical history of mild asthma. Normal diagnostic tests included urinalysis, glucose, creatinine and liver function. The subject's condition resolved by 15 May 2006. In the reporter's opinion, the events were possibly related to treatment with Engerix-B.
Narrative:  79yo male patient died on 1/8/2021 from stage 4 cancer in hospice care. Pt received covid vaccines on 1/29/2021 & 2/26/2021. This death is not related to covid vaccines.
Chills & shivering began around 11:00 pm of the evening of the vaccine day and lasted through the night and next morning.  Very bad headache.  Upon rising around 3:00 pm the following afternoon to use the bathroom, feeling very weak, passed out in the bathroom for just  a second or two.  Felt nauseous.  Husband picked me up and put me back in bed.  Registered low fever of 99.6.  Took 2 Tylenol which seemed to alleviate the headache about 50%.   Stayed in bed for balance of day.  The Monday following the Saturday of the vaccine, neck was very sore to the touch on both sides underneath my ears.  Could not lift head without aid.  Remained in bed the balance of the day.  Tuesday morning, felt good enough to get out of bed and resume regular activities but still only about 90%.
11/18/2022  I had a sore throat and a cough. I tested for COVID with an at home test and was positive. I called the doctor?s office and was prescribed Paxlovid on 11/20/22.  I got better very fast.
passed out after receiving a dose of Bexsero; This case was reported by a other health professional via call center representative and described the occurrence of passed out in a 16-year-old female patient who received Men B NVS (Bexsero) (batch number ABXA92AZ, expiry date 28th February 2022) for prophylaxis.   The patient's past medical history included suture insertion.   On 29th June 2020, the patient received Bexsero. On an unknown date, unknown after receiving Bexsero, the patient experienced passed out (serious criteria GSK medically significant). On an unknown date, the outcome of the passed out was unknown.   It was unknown if the reporter considered the passed out to be related to Bexsero.  Additional details were provided as follows: The age at vaccination was not reported. After receiving a dose of Bexsero, the patient passed out  The patient had to go to the Emergency Room to get stitches, following her passing out.  The reporter was consented for follow up. This was 1 of 3 linked cases reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020158058:same reporter US-GLAXOSMITHKLINE-US2020158060:same reporter
swelling in her jaw; This spontaneous report was received from a nurse practitioner via company representative and refers to a female patient of unknown age. Concomitant therapies included diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid and other unspecified vaccines. No information regarding the patient's pertinent medical history, concomitant medications and drug reactions or allergies was provided.   On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (dose, frequency, route of administration, anatomical location, lot number and expiration date was not provided) for prophylaxis. After the vaccination, she experienced swelling in her jaw described as "like she had her wisdom teeth pulled out". As a result, the nurse practitioner withheld the patient's subsequent dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9). The outcome of swelling in her jaw  was not provided.     The causality assessment between the event and the suspect therapy was not provided.
Patient's mother made call to hospital call center . patient c/o of chest pain since 4am today, 5/27/21, patient had Pfizer vaccine on 5/25/21.  pain non-radiating pain anywhere but only at the middle. I had not take any medications or done any interventions for this pain. I feel more lethargic when I walked around the house. The pain is better now comparing to this morning". Patient was not able to determine a pain score for this writer.
Systemic: Fainting / Unresponsive-Severe, Additional Details: Patient fainted 5 min post-vaccination while sitting on chair in observation area,fell forward & hit floor, skinning his nose. PhD immediately attended & rolled patient into recovery position as he awoke CphT left scene to call 911. Pharmacists, stayed w/ patient until EMS arrived (5 minutes) & transported to local hospital for evaluation
Pt stated he noted a bump at injection site after receiving a flu shot 2 weeks ago. Added he did not look at area but started scratching it through his shirt. Denies redness, swelling or pain. During assessment of site by medical director it was noted to be a dry, raised area the size of 1 x 0.9 cm. No signs of infection was noted and director advised pt to keep area clean and if it becomes reddened or swollen to return.
Narrative: COVID infections following completion of COVID vaccine series 03/10/21 COVID vaccine dose # 03/31/21 COVID vaccine dose #2 08/01/21 Pt calls reporting testing positive for COVID and flu-like symptoms -chills, cough, runny nose, sore throat, fatigue, muscle pain, diarrhea, nausea, headache 08/03/21 Pt reports not feeling well since Sat (07/31); rx given for ondansetron, vitamin D3, zinc 08/05/21 Pt reports cough is nearly improved bu continued fever, muscle pain, and runny nose 08/06/21 Pt reports fatigue but is improving clinically resolved
I got the first dose Feb 9th, I have not had the 2nd dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (I got the first dose Feb 9th, I have not had the 2nd dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (I got the first dose Feb 9th, I have not had the 2nd dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (I got the first dose Feb 9th, I have not had the 2nd dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.
Pt. received double dose of varicella, one Proquad, one Varivax.  Pt. did not have any adverse reactions.
ITCHING OF HANDS AND FEET, SWOLLEN-EYES, NOSE, LIPS, MOUTH, THROAT, AND HIVES ALL OVER LIMBS AND BUTTOCKS.
Pt received PREVNAR 13 on 10/20/17. Reports that she developed fever, chills starting 10/20/17 PM, along with redness, swelling and itching at site of vaccine injection. Called office 10/24/17 to report worsening redness, swelling and itching, fever gone, seen in office 10/25/17 with erythema and induration on R upper arm measuring 15 x 18 cm, mild tenderness at center where shot given. Prescribed 7 days of KEFLEX by MD.
Information has been received from a health professional concerning a 22 year old female who on 23-FEB-2007 was vaccinated with her second dose of GARDASIL.  Subsequently the patient experienced an abnormal pap at an unknown date.  The patient sought unspecified medical treatment.  The nurse noted that the patient has not returned for her third dose yet.  No other information was provided.  Additional information has been requested.
Vommiting, diarrhea, body ache, chills, no temperature. Right arm movement issues for 2 days. Bitter taste in mouth still ongoing.
About 6 hours after my shot, my arm to my fingers got numbness. About 12 hour later, my ankle swelled up twice this sizes. This is why I went to see the doctor for. My ankle finally went down after 2 weeks. I had to physical therapy. Now there is pain in my ankle.
Patient received second dose of the Moderna vaccine on 04/09/2021. After receiving vaccine, patient stated that she was diagnosed with Bell's Palsy after receiving the first dose of the Moderna vaccine. Patient stated that she started to experience some drooping to the left side of the face on 03/24/2021. Stated she was seen in the ER on 3/25/2021 and was diagnosed with Bell's Palsy per the ER doctor. Patient was prescribed steroids during the visit. Patient still experienced some mild drooping of the face at this visit.
First dose of covid vaccine on 2/17/2020, then hospitalized with covid disease 3/2/2020
Nothing at time of injection. One week later (1/29/21) I noticed red, bumpy, irritated area where shot was given.  Resolved itself 2 days later (1/31/21).
one week after vaccine patient developed redness, pain, rash, and inflammation at injection site.  Stated there was also a hard lump about the size of a half dollar at site.
Approximately 2 hours after receiving the flu shot, began feeling as if throat was closing off; throat and tongue were "on fire" and began wheezing. Presented to the ED at 8:05 pm. Was treated with Benadryl 25 mg IVP; Solu-Medrol 80 mg IVP; Albuterol 0.083% inhalation - Albuterol 2.5mg inhalation; and Pepcid 20mg IVPB.
Acute multifocal posterior placoid epitheliopathy right > left eye. eye pain and center vision haziness (as if she just got a camera flash in her eye)
Information has been received from a physician concerning an 11 year old female with penicillin allergy and no pertinent medical history who in January 2008, was vaccinated with a third dose of GARDASIL.  There was no concomitant medication.  In January 2008, the patient developed cataplexy 1 to 3 days after vaccination.  About 2 months later in March 2008, the patient developed narcolepsy with hallucinations and a limb movement disorder.  The patient was seen in the physician's office and was treated with an unknown stimulant.  On unspecified dates the patient had a computed axial tomography, poly sleep latency tests and an magnetic resonance imaging (MRI) was ordered.  At the time of reporting the patient had not recovered.  The physician considered the patient's cataplexy and narcolepsy with hallucinations and limb movement disorder were considered to be disabling and other medical events.  Additional information has been requested.  8/13/2008 Outpatient records received from 3/2008 to 6/2008 with fnal dx: narcolepsy. Pt initially developed sx of dizziness, fatigue, decreased energy, interupted sleep and episodes offalling asleep/losing bodily control but not fully passing out following 3rd HPV shot in 1/2008. Initially thought to be vasodepressive sx tx'd with increased salt and fluids without improvement. Seen once in ER in 2/2008 for episode of shuddering, weakness, excessive sleepines/syncope without dx. Seen by neuro with w/u WNL. Has had episodes of slurred speech and difficulty catching breath. Picture more c/w cataplexy/narcolepsy.
FEVER; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age, sex, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (unspecified manufacturer) (Dose number in series 1) (suspension for injection, route of admin not reported, batch number: unknown, expiry: unknown) dose, start therapy date were not reported, 1 total administered on an unspecified date for prophylactic vaccination. It was unknown whether patient had any adverse events following vaccination with first dose of covid-19 vaccine ad26.cov2.s. The patient received booster dose of covid-19 vaccine ad26.cov2.s (Dose number in series 2) (suspension for injection, route of admin not reported, batch number: unknown, expiry: unknown) dose, start therapy date were not reported, 1 total administered on an unspecified date for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced fever (Dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of fever was not reported. This report was non-serious.
22SEP91 hospitalized fever of 105; CXR done to determine if pt had pneumonia; dx uncertian but labled as Bronchitis @ the time required 02 discharged p/3 days;
sharp pain when breathing after having her first dose; a few kids were complaining of the same thing; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAINFUL RESPIRATION (sharp pain when breathing after having her first dose) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (a few kids were complaining of the same thing) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAINFUL RESPIRATION (sharp pain when breathing after having her first dose) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (a few kids were complaining of the same thing). At the time of the report, PAINFUL RESPIRATION (sharp pain when breathing after having her first dose) outcome was unknown and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (a few kids were complaining of the same thing) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication use was provided by the reporter.  Reporter stated that there was no clarification as to whether this was with the Moderna vaccine. No other information was provided. Consent was not received to contact school nurse. No contact information was provided for nurse on campus.  No treatment medications were reported.
Patient received J&J covid vaccine after completing consent and Prevaccination Checklist for COVID-19 vaccines. Patient was walked waiting room to sit for 15 minutes after injection. Patient reported to front desk staff she felt dizzy, staff instructed patient to sit in chair and take deep breathes. Patient sat down in chair and then had syncopal episode, witnessed by other patients in waiting room. Patient fell forward out of chair and hit face on floor causing laceration above left eyebrow. Patient was transferred to exam room where she continued to be lightheaded diaphoretic for approximately 15 minutes. Patient was slowly moved to sitting position, given orange juice to drink and laceration was treated. Patient was walked to vehicle approximately 30 minutes after syncopal episode and reported no further symptoms.
vaccine attempt unsuccessful. liquid leaked out of syringe or arm during attempt.  will advise to revaccinate as per cdc guidelines.
Patient was to receive Pfizer COVID-19 Dose 2. Pfizer COVID-19 Updated Booster (bivalent) was injected in error.
Patient stated he experienced hallucinations, muscle pain, right arm was red and hot on inside of the arm, face was red but had no fever, and has had insomina.
myalgia/arthralgia, significant weakness followed by reactivation of rapid ventricular rate w/ his chronic Atrial Fib leading to angina and hospitalization w/i 2 days of vaccine.  symptoms have not yet recovered, resulting in SNF placement
headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received first dose of bnt162b2 (BNT162B2, Batch/Lot number: Unknown) administration date 04Mar2021 as DOSE 1, SINGLE for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious) with onset 04Mar2021, outcome "unknown", described as "headache".  No follow-up attempts are possible. No further information is expected.
Less than minute after shot, pain in arm, nausea, sick feeling, had to lay down, passed in 5 minutes. Fatigue and flue-like aches and pains for the rest of the day. Pain in arm remained for 2 days.
Tiredness; alternating hot and cold; Muscle pain; This case was reported by a consumer via call center representative and described the occurrence of muscle pain in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced muscle pain, tiredness and feeling hot and cold. On an unknown date, the outcome of the muscle pain, tiredness and feeling hot and cold were unknown.   It was unknown if the reporter considered the muscle pain, tiredness and feeling hot and cold to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient experienced muscle pain, tiredness and alternating hot and cold. The reporter was unwilling to provide additional details.
Pt presented recently to anti-coagulation clinic with supra-therapeutic INR of 4.1. Pt has been on stable dose of warfarin with INRs in range 90% of the time with only small excursions (0.1-0.2) since 2016. He received Johnson and Johnson vaccine on 4/10 at outside facility, brought in his vaccine card. He states only arm pain and no other side effects from vaccine (although well known to providers here to minimize complaints). He took 4 doses of Advil the day after the vaccine (has taken prn Advil for years while on warfarin). 4/13 came in for INR check, INR was 4.1. He is clinically fine, no bleeding. History and exam did not find any other causes for elevated INR in this otherwise very stable patient.
Giant hive on right side of my body above my right thigh, on the side of my hip.
My wife noticed the area where I received the vaccine was red, warm, and having a reaction. She then noticed the Tdap vaccine was given to me subcutaneous, instead of intramuscular.
stiffness @ inject site lt deltoid following vax which cont until AUG92 in the evening when extreme pain & soreness occurred & impaired use of arm; seen by MD 24AUG92 dx post inject myositis;
child looked pale, stated it hurts slumped to rt & appeared to lose consciousness;nurse was able to prevent child from hitting floor w/assistance;
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65-year-old male patient received BNT162b2 (BNT162B2), on 11Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 65 years, in left arm for covid-19 immunisation; COVID-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: PRAVASTATIN, start date: 10Jan2022, stop date: 12Sep2022. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive; (23Sep2022) Positive, notes: Positive test 7 days after paxlovid 5 day dosage. Therapeutic measures were taken as a result of drug ineffective, covid-19 which included Paxlovid treatment from 12Sep2022 to 16Sep2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.